Chuan Jin
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Magnus Essand
- Mobile phone:
- +46 76 266 63 83
- E-mail:
- chuan.jin@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA

Publications
Recent publications
-
Part of Molecular Cancer Therapeutics, p. 469-479, 2026
- DOI for Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Download full text (pdf) of Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Part of Cancer Gene Therapy, p. 297-305, 2025
- DOI for Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
- Download full text (pdf) of Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
-
Part of Cancer Immunology and Immunotherapy, 2025
- DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
-
Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
-
Part of Frontiers in Immunology, 2023
- DOI for Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
- Download full text (pdf) of Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
All publications
Articles in journal
-
Part of Molecular Cancer Therapeutics, p. 469-479, 2026
- DOI for Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Download full text (pdf) of Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Part of Cancer Gene Therapy, p. 297-305, 2025
- DOI for Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
- Download full text (pdf) of Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
-
Part of Cancer Immunology and Immunotherapy, 2025
- DOI for Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Download full text (pdf) of Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
-
Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
-
Part of Frontiers in Immunology, 2023
- DOI for Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
- Download full text (pdf) of Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
-
A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
Part of Frontiers in Molecular Biosciences, 2022
- DOI for A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
- Download full text (pdf) of A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
-
Part of Oncoimmunology, 2022
- DOI for Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
- Download full text (pdf) of Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
-
ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
Part of Frontiers in Immunology, 2022
- DOI for ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
- Download full text (pdf) of ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
-
Part of Nature Biomedical Engineering, p. 830-841, 2022
- DOI for CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
- Download full text (pdf) of CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
-
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 356-366, 2021
- DOI for Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
- Download full text (pdf) of Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
-
Part of Cell Death and Disease, 2020
- DOI for Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Download full text (pdf) of Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
Part of Journal of Pathology, p. 228-240, 2019
-
Part of Oncoimmunology, 2018
- DOI for Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
- Download full text (pdf) of Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
-
Part of Oncoimmunology, 2018
-
Part of Scandinavian Journal of Immunology, p. 341-341, 2017
-
Part of Molecular Therapy, p. 288-288, 2017
-
Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
Part of Immunotherapy, p. 1355-1361, 2016
-
Part of CANCER IMMUNOLOGY RESEARCH, 2016
-
Long-term episomal gene transfer for safe engineering of T cells for adoptive cell therapy of cancer
Part of CANCER IMMUNOLOGY RESEARCH, 2016
-
Part of EMBO Molecular Medicine, p. 702-711, 2016
- DOI for Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
- Download full text (pdf) of Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
-
Part of Science Signaling, 2015
-
Long-term episomal gene transfer for safe engineering of T-cells for adoptive cell therapy of cancer
Part of Human Gene Therapy, 2014
-
Part of Molecular Therapy Methods & Clinical Development, 2014
-
Part of Journal of Immunology, p. 2287-2296, 2014
-
Part of Molecular Therapy, 2014
-
Part of Molecular Therapy, 2014
-
Engineering Regulatory Cells With a T Cell Receptor for Controlled Activation
Part of Molecular Therapy, 2014
-
Part of PLOS ONE, 2013
- DOI for Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
- Download full text (pdf) of Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
-
Part of Human Gene Therapy, p. 766-775, 2013
- DOI for Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
- Download full text (pdf) of Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
-
Part of Journal of Virology, p. 13114-13123, 2011
- DOI for Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- Download full text (pdf) of Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors